Jw Pharmac Cash Flow Quality Index
Jw Pharmac cash flow quality index. Jw Pharmac (001060) has a Cash Flow Quality Index of 0.64x as of March 2026. Operating cash flow of ₩17.50 Billion is below net income of ₩27.48 Billion, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Jw Pharmac to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jw Pharmac (2001–2025)
Cash flow quality index of Jw Pharmac from 2001 to 2025. Historical Cash Flow Quality Index for Jw Pharmac across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jw Pharmac debt service capacity to assess how comfortably operating cash covers total debt obligations.
Jw Pharmac Cash Flow Quality Index by Year (2001–2025)
Jw Pharmac cash flow quality index by year from 2001 to 2025. Year-by-year earnings quality comparison for Jw Pharmac. For the full cash flow conversion analysis, see Jw Pharmac (001060) cash conversion ratio.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | ₩96.40 Billion | ₩61.51 Billion | ▲ +28.4% |
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | ▼ -118.0% |
| 2014 | 11.80x | ₩7.28 Billion | ₩617.05 Million | ▲ +41.4% |
| 2013 | 8.34x | ₩18.72 Billion | ₩2.24 Billion | ▲ +1814.8% |
| 2006 | 0.44x | ₩5.07 Billion | ₩11.65 Billion | ▼ -94.4% |
| 2005 | 7.74x | ₩70.25 Billion | ₩9.08 Billion | ▲ +548.9% |
| 2004 | 1.19x | ₩15.02 Billion | ₩12.59 Billion | ▼ -25.1% |
| 2003 | 1.59x | ₩17.05 Billion | ₩10.71 Billion | ▼ -39.7% |
| 2002 | 2.64x | ₩28.74 Billion | ₩10.89 Billion | ▼ -39.9% |
| 2001 | 4.39x | ₩45.04 Billion | ₩10.26 Billion | — |